Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
BioDelivery Sciences International Inc (NASDAQ: BDSI)

Organization & Developments: Biodelivery

Parents

* BEMA® (or BioErodibleMucoAdhesive) drug delivery technology, which consists of a small dissolvable polymer film for application to mucosal membranes (inner lining of cheek) for transmucosal delivery of drugs for time critical conditions.
* Bioral® drug delivery technology, which is based upon a novel process of encapsulating or protecting a drug to facilitate oral dosing of drugs otherwise given by intravenous administration.
*Organization & Developments: Biodelivery (2012-2017)
2018: A Post-Earnings Assessment On BioDelivery Sciences_seekingalpha.com
2018: BioDelivery Delivers Again
2018: BioDelivery Sciences Continues To Roll_seekingalpha.com
2018: BioDelivery Sciences: Buy The Dip - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2018: Reader Inquiry: At 52-Week Lows Is BioDelivery Sciences A Viable Turnaround Play? - BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
2018: Updated Investment Case On BioDelivery Sciences_seekingalpha.com
2019: Another Big Quarter For BioDelivery Sciences_seekingalpha.com
2019: BioDelivery Sciences: Updates To Thesis, BELBUCA Growth Continues To Impress_seekingalpha.com
2019: Checking In On BioDelivery Sciences_seekingalpha.com
2020: BioDelivery Sciences: Another Solid Quarter
2020: Keep The Faith On This $4 Biopharma Stock
2021: BioDelivery Sciences: Still Delivering Impressive Growth
BDSI’s product Onsolis delivers the painkiller fentanyl through a small piece of film placed on the inside of the cheek.